Finance

Lists
RXST:NASDAQ
Rxsight Inc
$5.20
-2.26%
(-0.12) 1D
$5.20
0.00% (0.00)
After hours
Closed: Sep 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RXST...
Open
$5.25
High
$5.36
Low
$5.16
Mkt. cap
216.28M
Avg. vol.
839.64K
Volume
1.08M
52-wk high
$13.22
52-wk low
$4.48
EPS
-$1.14
Beta
1.17
Shares outstanding
41.59M
No. of employees
461
Open
$5.25
High
$5.36
Low
$5.16
Mkt. cap
216.28M
Avg. vol.
839.64K
Volume
1.08M
52-wk high
$13.22
52-wk low
$4.48
EPS
-$1.14
Beta
1.17
Shares outstanding
41.59M
No. of employees
461
News stories
From web sources and news partners
About Rxsight Inc
CEO-
Employees461
Founded1997
HeadquartersAliso Viejo, California, United States
SectorMedical device
Websiterxsight.com
Analyst ratings
Based on 10 analysts giving stock ratings to RXST in the past 3 months
Hold
Buy
1
Hold
7
Sell
2
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for RXST in the last 3 months.
Highest
Current $5.20
$11.00 (+111.54%)
Average
$7.79 (+49.81%)
Lowest
$6.00 (+15.38%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Stephan
Stifel Nicolaus
Hold
Maintained
$7.00
+34.6%
08/10/2026
Steven Lichtman
William Blair
Hold
Maintained
-
-
08/07/2026
Robbie Marcus
J.P. Morgan
Sell
Maintained
$6.00
+15.4%
08/06/2026
Travis Steed
Bank of America Securities
Sell
Reiterated
$6.50
+25%
08/05/2026
Patrick Wood
UBS
Hold
Maintained
$6.30
+21.2%
08/06/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$9.00
+73.1%
08/06/2026
Adam Maeder
Piper Sandler
Hold
Maintained
$10.00
+92.3%
08/06/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
08/06/2026
David Saxon
Needham
Buy
Maintained
$11.00
+111.5%
08/06/2026
Danielle Antalffy
UBS
Hold
Initiated
$5.50
+5.8%
07/28/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
$9.00
+73.1%
07/08/2026
Young Li
Jefferies
Hold
Maintained
$6.50
+25%
07/07/2026
Craig Bijou
Bank of America Securities
Sell
Maintained
$6.50
+25%
07/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
30.34M
32.61M
30.89M
33.74M
Cost of goods sold
6.11M
7.34M
7.40M
7.86M
Cost of revenue
6.11M
7.34M
7.40M
7.86M
Research and development expenses
9.06M
8.90M
9.47M
9.24M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.34M
27.70M
31.86M
30.42M
Operating expense
36.40M
36.60M
41.33M
39.66M
Total operating expenses
42.52M
43.94M
48.72M
47.51M
Operating income
-12.18M
-11.34M
-17.83M
-13.77M
Other non operating income
-
-
-
-
EBT including unusual items
-9.81M
-9.15M
-15.88M
-12.01M
EBT excluding unusual items
-9.81M
-9.15M
-15.88M
-12.01M
Income tax expense
10.00K
5.00K
6.00K
88.00K
Effective tax rate
-0.10%
-0.05%
-0.04%
-0.73%
Other operating expenses
-
-
-
-
Net income
-9.82M
-9.15M
-15.88M
-12.10M
Net profit margin
-32.35%
-28.07%
-51.42%
-35.85%
Earnings per share
-0.04
-0.03
-0.19
-0.11
Interest and investment income
2.38M
2.20M
1.95M
1.76M
Interest expense
-4.00K
-5.00K
-3.00K
-3.00K
Net interest expenses
2.37M
2.19M
1.95M
1.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.32M
-10.49M
-17.00M
-12.77M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps